SLC6A3 and Parkinson disease: There is accumulating evidence that reduced DAT binding, a reflection of striatal dopaminergic denervation, predicts a high future risk of PD in individuals with prodromal clinical features such as iRBD, hyposmia, or symptoms of autonomic dysfunction.5,9 While a normal DAT SPECT scan does not eliminate risk of future PD, it is likely that individuals with a normal DAT SPECT are at a lower risk over the next few years of developing PD compared to those with an abnormal scan.